Results 241 to 250 of about 69,829 (275)
Some of the next articles are maybe not open access.
Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose.
Annals of Internal Medicine, 2004 S. Hadziyannis, H. Sette, T. Morgan, V. Balan, M. Diago, P. Marcellin, G. Ramadori, H. Bodenheimer, D. Bernstein, M. Rizzetto, S. Zeuzem, P. Pockros, A. Lin, A. Ackrill +13 moresemanticscholar +1 more sourceInhibition of Warfarin Activity by Ribavirin
Annals of Pharmacotherapy, 2002 OBJECTIVE: To report a case of inhibition of the effect of warfarin during treatment with ribavirin. CASE SUMMARY: A 61-year-old white man received combination treatment with interferon and ribavirin during 1 year for chronic hepatitis C. He was on permanent anticoagulant therapy with warfarin after a previous heart valve replacement.openaire +3 more sourcesIL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy
Nature Genetics, 2009 V. Suppiah, Max Moldovan, G. Ahlenstiel, T. Berg, M. Weltman, M. Abate, M. Bassendine, U. Spengler, G. Dore, E. Powell, S. Riordan, D. Sheridan, A. Smedile, V. Fragomeli, T. Müller, M. Bahlo, G. Stewart, D. Booth, J. George +18 moresemanticscholar +1 more sourceGenome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C
Nature Genetics, 2009 Yasuhito Tanaka, N. Nishida, M. Sugiyama, M. Kurosaki, K. Matsuura, N. Sakamoto, M. Nakagawa, M. Korenaga, K. Hino, S. Hige, Yoshito Ito, E. Mita, E. Tanaka, S. Mochida, Y. Murawaki, M. Honda, A. Sakai, Y. Hiasa, S. Nishiguchi, A. Koike, I. Sakaida, M. Imamura, Kiyoaki Ito, K. Yano, N. Masaki, F. Sugauchi, N. Izumi, K. Tokunaga, M. Mizokami +28 moresemanticscholar +1 more sourceSimeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study
The Lancet, 2014 E. Lawitz, M. Sulkowski, R. Ghalib, M. Rodríguez-Torres, Z. Younossi, A. Corregidor, E. Dejesus, Brian L. Pearlman, M. Rabinovitz, N. Gitlin, Joseph K. Lim, P. Pockros, John D. Scott, B. Fevery, Tom Lambrecht, S. Ouwerkerk-Mahadevan, K. Callewaert, W. Symonds, G. Picchio, K. Lindsay, M. Beumont, I. Jacobson +21 moresemanticscholar +1 more sourceSofosbuvir and ribavirin for treatment of compensated recurrent hepatitis C virus infection after liver transplantation.
Gastroenterology, 2015 M. Charlton, E. Gane, M. Manns, Robert S. Brown, M. Curry, P. Kwo, R. Fontana, R. Gilroy, L. Teperman, A. Muir, J. Mchutchison, W. Symonds, D. Brainard, B. Kirby, H. Dvory‐Sobol, J. Denning, S. Arterburn, D. Samuel, X. Forns, N. Terrault +19 moresemanticscholar +1 more source
